An Integrative Review of Cancer: Etiology, Clinical Presentation, and Treatment Modalities in Modern Medicine and Ayurveda

Article Sidebar

PDF
Published: Mar 29, 2021
DOI: https://doi.org/10.53555/jrtdd.v4i1.3814
Keywords:
Cancer; Oncology; Neoplasms; Ayurveda; Arbuda; Integrative Medicine; Palliative Care; Tridosha; Panchakarma; Rasayana.

Main Article Content

Dr. Rashmi Gupta

Abstract

Cancer constitutes a major global health burden, characterized by uncontrolled cellular proliferation and metastatic potential. This review provides a comprehensive analysis of cancer from modern and Ayurvedic perspectives. We delineate the modern understanding, covering its definition, incidence, multifactorial etiology, and common clinical presentations. The cornerstone treatment modalities of modern oncology—surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy—are detailed alongside their limitations, including systemic toxicity and resistance. Parallelly, the article explores the conceptualization of cancer in Ayurveda, often correlated with Arbuda, a condition arising from the aggravation of the Tridoshas (Vata, Pitta, Kapha) and the accumulation of Ama (toxins). The review synthesizes the principles of Ayurvedic management, including Shodhana (bio-purification),  Shamana (palliation), and Rasayana (rejuvenation). We discuss the growing evidence supporting the role of these modalities as complementary care for mitigating side-effects of conventional treatments and improving quality of life. The conclusion underscores the promise of an integrative oncology model that synergizes the strengths of modern biomedical science with the holistic principles of Ayurveda. This paradigm warrants further rigorous preclinical and clinical investigation to establish standardized, evidence-based protocols for comprehensive cancer care.

Article Details

How to Cite
Dr. Rashmi Gupta. (2021). An Integrative Review of Cancer: Etiology, Clinical Presentation, and Treatment Modalities in Modern Medicine and Ayurveda. Journal for ReAttach Therapy and Developmental Diversities, 4(1), 127–139. https://doi.org/10.53555/jrtdd.v4i1.3814
Issue
Vol. 4 No. 1 (2021): January-June 2021
Section
Articles
Author Biography

Dr. Rashmi Gupta

Associate Professor, Department of Shalya Tantra, Faculty of Ayurveda, Institute of Medical Sciences (IMS), Banaras Hindu University (BHU), Varanasi 221005

References

Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000 Jan 7;100(1):57-70. doi: 10.1016/s0092-8674(00)81683-9.

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.

Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022 Jan;12(1):31-46. doi: 10.1158/2159-8290.CD-21-1059.

Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 1993 Apr;9(4):138-41. doi: 10.1016/0168-9525(93)90209-z.

Weinberg RA. The Biology of Cancer. 2nd ed. New York: Garland Science; 2014.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834.

Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016 Sep;48(3):889-902. doi: 10.1183/13993003.00359-2016.

Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020 Feb;8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6.

McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of Hepatocellular Carcinoma. Hepatology. 2021 Mar;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288.

Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005.

Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol. 2012 Aug;13(8):790-801. doi: 10.1016/S1470-2045(12)70211-5.

Nagy R, Sweet K, Eng C. Highly penetrant hereditary cancer syndromes. Oncogene. 2004 Aug 23;23(38):6445-70. doi: 10.1038/sj.onc.1207714.

Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.

Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003 Oct;3(10):733-44. doi: 10.1038/nrc1190.

de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020 Feb;8(2):e180-e190. doi: 10.1016/S2214-109X(19)30488-7.

Greinert R, de Vries E, Erdmann F, Espina C, Auvinen A, Kesminiene A, Schüz J. European Code against Cancer 4th Edition: Ultraviolet radiation and cancer. Cancer Epidemiol. 2015 Dec;39 Suppl 1:S75-83. doi: 10.1016/j.canep.2014.12.006.

Rushton L, Hutchings SJ, Fortunato L, et al. Occupational cancer burden in Great Britain. Br J Cancer. 2012 Jun 19;107 Suppl 1(Suppl 1):S3-S7. doi: 10.1038/bjc.2012.112.

Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008 Aug;67(3):253-6. doi: 10.1017/S002966510800712X.

Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K; International Agency for Research on Cancer Handbook Working Group. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016 Aug 25;375(8):794-8. doi: 10.1056/NEJMsr1606602.

Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019 May;69(3):184-210. doi: 10.3322/caac.21557.

van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007 Sep;18(9):1437-49. doi: 10.1093/annonc/mdm056.

Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng KK, Marshall T. The importance of anaemia in diagnosing colorectal cancer: a case-control study using electronic primary care records. Br J Cancer. 2008 Jan 15;98(2):323-7. doi: 10.1038/sj.bjc.6604165.

Hamilton W, Sharp D. Diagnosis of lung cancer in primary care: a structured review. Fam Pract. 2004 Dec;21(6):605-11. doi: 10.1093/fampra/cmh605.

Jones RV. Use of alarm symptoms in primary care. BMJ. 2007 Oct 20;335(7624):784. doi: 10.1136/bmj.39345.439769.AD.

Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol. 1996 May;34(5 Pt 1):839-47. doi: 10.1016/s0190-9622(96)90071-7.

Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011 May;12(5):489-95. doi: 10.1016/S1470-2045(10)70218-7.

Berger AM, Mooney K, Alvarez-Perez A, et al. Cancer-Related Fatigue, Version 2.2015. J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39. doi: 10.6004/jnccn.2015.0122.

Zell JA, Chang JC. Neoplastic fever: a neglected paraneoplastic syndrome. Support Care Cancer. 2005 Nov;13(11):870-7. doi: 10.1007/s00520-005-0825-4.

Balch CM, Gershenwald JE, Soong SJ, Thompson JF. Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. J Surg Oncol. 2011 Sep;104(4):379-85. doi: 10.1002/jso.21876.

Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3):193-9. doi: 10.7150/ijms.3635.

Chabner BA, Roberts TG Jr. Timeline: Chemotherapy and the war on cancer. Nat Rev Cancer. 2005 Jan;5(1):65-72. doi: 10.1038/nrc1529.

Gross S, Rahal R, Stransky N, Lengauer C, Hoeflich KP. Targeting cancer with kinase inhibitors. J Clin Invest. 2015 May;125(5):1780-9. doi: 10.1172/JCI76094.

Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020 Nov;20(11):651-668. doi: 10.1038/s41577-020-0306-5.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015 Oct 3;386(10001):1341-52. doi: 10.1016/S0140-6736(15)61074-1.

Murthy ARV, Singh RH. The concepts of Daiva and Purushakara in Ayurveda. Anc Sci Life. 1987 Jul;7(1):1-7.

Rastogi S. Building bridges between Ayurveda and modern science. Int J Ayurveda Res. 2010 Jan;1(1):41-6. doi: 10.4103/0974-7788.59943.

Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res. 1999 Jun;13(4):275-91. doi: 10.1002/(SICI)1099-1573(199906)13:4<275::AID-PTR510>3.0.CO;2-S.

Tripathi JS, Singh RH. Concept of Sattvavajaya Chikitsa (Psychotherapy) in Ayurveda. Anc Sci Life. 1998 Oct;18(2):153-9.

U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.

World Cancer Research Fund / American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Available at: dietandcancerreport.org.

McTiernan A, Friedenreich CM, Katzmarzyk PT, et al. Physical Activity in Cancer Prevention and Survival: A Systematic Review. Med Sci Sports Exerc. 2019;51(6):1252-1261. doi:10.1249/MSS.0000000000001937.

Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018;5(5):CD009069. Published 2018 May 9. doi:10.1002/14651858.CD009069.pub3.

Chang MH. Hepatitis B virus and cancer prevention. Recent Results Cancer Res. 2011;188:75-84. doi:10.1007/978-3-642-10858-7_6.

Leiter U, Keim U, Garbe C. Epidemiology of Skin Cancer: Update 2019. Adv Exp Med Biol. 2020;1268:123-139. doi:10.1007/978-3-030-46227-7_6.

Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184-210. doi:10.3322/caac.21557.

Cuzick J, Thorat MA, Bosetti C, et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Ann Oncol. 2015;26(1):47-57. doi:10.1093/annonc/mdu225.

World Health Organization (WHO). Palliative Care. [Key Facts]. Retrieved from: https://www.who.int/news-room/fact-sheets/detail/palliative-care

Swarm RA, Paice JA, Anghelescu DL, et al. Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(8):977-1007. doi:10.6004/jnccn.2019.0038.

National Consensus Project for Quality Palliative Care. Clinical Practice Guidelines for Quality Palliative Care, 4th Edition. Richmond, VA: National Coalition for Hospice and Palliative Care; 2018. Available at: https://www.nationalcoalitionhpc.org/ncp

Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-742. doi:10.1056/NEJMoa1000678.